DTIL analyst estimates
Precision BioSciences (DTIL) analyst ratings, the average price target and its range, and every firm's latest call.
DTIL analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Jun 9, 2026 | Oppenheimer | Precision BioSciences initiated with an Outperform at Oppenheimer | $20.00 |
| Mar 13, 2026 | Jefferies | Precision BioSciences Inc. (DTIL) PT Lowered to $19 at Jefferies, but 'near-term setup is attractive' | $19.00 |
| Apr 1, 2024 | BTIG | Precision BioSciences price target raised to $30 from $2 at BTIG | $30.00 |
| Nov 10, 2022 | Goldman Sachs | Goldman Sachs Maintains Neutral on Precision BioSciences, Lowers Price Target to $1 | $1.00 |
- 2 firms rate DTIL: 2 buy, 0 hold, 0 sell.
- The average price target is $20.00 from 1 analysts, from $20.00 to $20.00.
Updated 2026-11-05 18:47 UTC